PM2.5与O3对中国肺癌患者生存获益的独立与联合关联:北京20年登记队列研究
每10μg/m3增加,PM2.5的HR为1.111(95%CI 1.083-1.140),O3的HR为1.117(95%CI 1.070-1.166);两者存在显著相乘交互,主要见于O3>105µg/m3。
要点
- 长期PM2.5和O3暴露均独立增加肺癌患者死亡风险,每10μg/m3的HR分别为1.111和1.117。
- PM2.5与O3存在显著相乘交互,高O3(>105µg/m3)时正交互显著。
- PM2.5下降带来生存获益,但O3升高及交互抵消约40%获益,支持多污染物协同治理。
核心结论
- PM2.5和O3长期暴露均与肺癌患者全因死亡风险增加独立相关,且存在显著相乘交互。
- PM2.5下降带来显著生存获益,但O3升高及PM2.5-O3交互抵消约40%的获益。
研究设计与样本
- 采用ChinaHighAirPollutants数据集分配诊断前3年平均PM2.5和O3暴露,Cox比例风险模型估计关联。
- 使用二维张量积样条检验联合暴露-反应模式,以相乘交互指数量化交互,并基于2013年暴露水平进行反事实模拟估算避免死亡和预期寿命延长。
主要发现
- PM2.5每增加10μg/m3,全因死亡HR为1.111(95%CI 1.083-1.140);O3每增加10μg/m3,HR为1.117(95%CI 1.070-1.166)。
- PM2.5与O3存在显著相乘交互,统计学显著的正交互主要出现在O3浓度>105µg/m3时。
- O3及PM2.5-O3交互抵消了上述获益的约40%。
临床怎么用
- 评估肺癌患者空气污染暴露时,应同时关注PM2.5和O3,而非仅关注PM2.5。
- 大气治理需协同控制PM2.5和O3,以最大化肺癌患者生存获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent years, China has experienced declining fine particulate matter (PM2.5) levels but rising ozone (O3) levels. We aimed to examine the independent and joint associations of long-term exposure to PM2.5 and O3 with all-cause mortality among patients with lung cancer and to estimate potential survival gains. METHODS: We included 172 845 lung cancer patients diagnosed in 2003-2022 from the Beijing Cancer Registry. Three-year average pre-diagnosis PM2.5 and O3 were assigned using the ChinaHighAirPollutants dataset. Cox proportional hazards models were used to estimate associations of PM2.5 and O3 with mortality. Joint exposure-response patterns were examined using a two-dimensional tensor-product spline and quantified by the multiplicative interaction index. Model-estimated avoided deaths and extended expected lifespan (EEL) were calculated using counterfactual simulations based on 2013 exposure levels. RESULTS: Both PM2.5 and O3 were associated with increased mortality among patients with lung cancer, with HRs of 1.111 for PM2.5 (95% CI 1.083 to 1.140) and 1.117 for O3 (95% CI 1.070 to 1.166) per 10 μg/m3 increase. A significant multiplicative interaction was observed between PM2.5 and O3, with statistically significant positive interactions mainly occurring at higher O3 concentrations (>105 µg/m3). During 2016-2022, reductions in pre-diagnosis PM2.5 exposure were associated with 13 229 model-estimated avoided deaths and a 7.8-month increase in 5-year EEL. However, O3 and the PM2.5-O3 interaction offset approximately 40% of these benefits. DISCUSSION: PM2.5 reduction was associated with substantial survival gains among lung cancer patients, but rising O3 and pollutant interactions partly offset these benefits, supporting coordinated multipollutant control.
引用
- Yang L, Kang N, Xue T, et al. PM2.5, O3 and survival gains from China's clean air actions among patients with lung cancer: a 20-year registry-based cohort study in Beijing. Thorax. 2026. PMID: 42778299. doi:10.1136/thorax-2026-225199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。